CROCE CARLO M has a total of 65 patent applications. Its first patent ever was published in 2003. It filed its patents most often in United States and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets biotechnology, pharmaceuticals and machines are CANCER INST CAMS, SINOGENOMAX CO LTD and SUNGKWANG MEDICAL FOUNDATION.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 56 | |
#2 | WIPO (World Intellectual Property Organization) | 9 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | Machines | |
#4 | Measurement | |
#5 | Agriculture | |
#6 | Medical technology | |
#7 | Foods and drinks |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Measuring microorganism processes | |
#3 | Microorganisms | |
#4 | Medical preparations | |
#5 | Unspecified technologies | |
#6 | Analysing materials | |
#7 | Peptides | |
#8 | Animal care | |
#9 | Electrotherapy | |
#10 | Enzymes |
# | Name | Total Patents |
---|---|---|
#1 | Croce Carlo M | 65 |
#2 | Calin George A | 25 |
#3 | Volinia Stefano | 18 |
#4 | Harris Curtis C | 12 |
#5 | Schetter Aaron J | 9 |
#6 | Garzon Ramiro | 4 |
#7 | Pekarsky Yuri | 3 |
#8 | Guttridge Denis C | 3 |
#9 | Budhu Anuradha | 2 |
#10 | Huebner Frances K | 2 |
Publication | Filing date | Title |
---|---|---|
WO2015138426A1 | Compositions and methods for treating cachexia | |
US2013065938A1 | Mutator activity induced by microRNA-155 (miR-155) links inflammation and cancer | |
WO2011137288A2 | Mirna networks in cancers and leukemias and uses thereof | |
WO2010099161A1 | Micrornas in never-smokers and related materials and methods | |
US2011311555A1 | Tc11 as a Transcriptional Regulator | |
US2012010092A1 | Methods for identifying fragile histidine triad (FHIT) interaction and uses thereof | |
US2010120898A1 | MicroRNA expression signature for predicting survival and metastases in hepatocellular carcinoma |